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Myeloid/lymphoid or mixed-lineage leukemia; translocated to chromosome 11 or ALL1 fused from
chromosome 1q (MLLT11/AF1q) is a highly conserved 90 amino acid protein that functions in hematopoi-
etic differentiation. Its translocation to the Trithorax locus has been implicated in malignancies of the
hematopoietic system. However, the spatio-temporal proﬁle of MLLT11 expression during embryonic
development has not been characterized. Here we show that MLLT11 has a remarkably speciﬁc expres-
sion pattern in the developing central and peripheral nervous system. We ﬁnd high levels of MLLT11
transcript and protein expression in the developing marginal zone of the cortex and spinal cord. MLLT11
co-localized with Tbr2 in the developing subplate region of the cortex and expanded to encompass the
cortical plate at late fetal stages. Expression in the peripheral nervous system initiated at E9.5 in the
facio-acoustic cranial ganglia and elaborated to identify all the cranio-facial and dorsal root ganglia by
E10.5. We also observed expression in the eye and gastrointestinal tract, where MLLT11 transcripts
localized to Tuj1-positive inner retinal layer and autonomic neurons, respectively. Altogether these
results show that MLLT11 is a pan-neuronal marker, suggesting a role in neural differentiation in the
central nervous system and neural crest-cell derived peripheral ganglia.
Crown Copyright  2014 Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).The formation of the nervous system requires the coordinated
activities of signaling proteins acting through speciﬁc gene expres-
sion programs. While much progress has been made on the eluci-
dation of the role of various signaling pathways, there is still much
to learn regarding the molecular control of neurogenesis. This
involves identifying novel regulators of neuronal differentiation
and maintenance programs during brain development. Here we
describe the expression pattern of a novel protein, MLLT11/AF1q,
in the development of neurons in both the peripheral and central
nervous system.
MLLT11/AF1q (hereafter referred to as MLLT11) was ﬁrst identi-
ﬁed in leukemia cells as a fusion partner formixed lineage leukemia
(MLL) protein, hence called ‘myeloid/lymphoid or mixed-lineage
leukemia; translocated to chromosome 110 or ‘ALL1 fused from
chromosome 1q’ (Tse et al., 1995). MLLT11 is a 90 amino acid pro-
tein with highly conserved residues, containing a MLLT11 motifs
and a nuclear export signal (Parcelier et al., 2011). Various chromo-
somal rearrangements including duplication and translocation ofMLLT11 locus have been reported in hematopoietic malignancies
(Le Baccon et al., 2001). Elevated MLLT11 mRNA was associated
with a poor prognosis in pediatric acute myeloid leukemia patients
(Tse et al., 2004). Based on this circumstantial evidence, MLLT11
has been regarded as an oncogenic protein, although its function
in hematopoietic malignancies is not well understood. A recent
study demonstrated a role for MLLT11 in promoting T-cell
development from multipotent hematopoietic stem cells while
antagonizing B-cell differentiation (Parcelier et al., 2011). Thus,
besides its oncogenic activity, MLLT11 plays a role in cell fate
speciﬁcation.
The spatio-temporal expression pattern of MLLT11 during
embryonic development is currently unknown. Previous work
showed that MLLT11 is expressed in the immature hematopoietic
stem cells in the thymus and in leukemia cell lines (Tse et al.,
1995; Parcelier et al., 2011). While a study has described the
detection of MLLT11 in lysates of the embryonic mouse brain
(Lin et al., 2004), the detailed expression pattern of MLLT11 during
development has not been reported. To gain further insight into
the role of MLLT11 in the nervous system, we examined the
spatial–temporal expression proﬁle of MLLT11 during mouse
neurogenesis. Here we report that MLLT11 is a highly speciﬁc mar-
ker of the emergence of post-mitotic neurons in the central and
peripheral nervous system during mouse development.
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1.1. MLLTT11 expression in cranial ganglia
To assess the spatial–temporal expression pattern of MLLT11,
in situ hybridization (ISH) was performed at different stages of
embryonic neurogenesis. MLLT11 mRNA was ﬁrst detected at E9.5
in the facio-acoustic (VII–VIII) ganglion complex (Fig. 1A), then sub-
sequently in the trigeminal (V) ganglion, glossopharyngeal (IX) gan-
glion, superior and inferior vagus (X) ganglia, and dorsal root ganglia
at E10.5 (Fig. 1B). While the sense riboprobe did not stain cranial
ganglia at E10.5, expression was detected in the otic vesicle (OV,
Fig. 1B). This could be caused by non-speciﬁc probe trapping, or
the detection of Cdc42 transcripts, which are encoded in the genome
in opposite orientation relative to MLLT11 coding sequences (data
not shown). Interestingly, Cdc42 is a Rac GTPase that has been
implicated in otocyst development (Grimsley-Myers et al., 2012),
thus the sense riboprobe may be speciﬁc for Cdc42 mRNA. MLLT11
mRNA was also found in the basal region of the forebrain, midbrain
and hindbrain at E10.5 and E11.5 (arrowheads, Fig. 1B; ⁄, Fig. 2A).
We conﬁrmed that regions that were positive for MLLT11 mRNA
were post-mitotic neurons by virtue of its co-expression with Tuj1
(Fig. 1A0, B0 and Fig. 2A0–B00).
1.2. MLLT11 expression in the developing cortex
In the developing cerebral cortex, MLLT11 was ﬁrst detected in
the outermost layer of the telencephalon at E11.5, which was posi-
tive for Tuj1 and negative for Sox2, a nuclear marker for neural
progenitors (Fig. 2A-A00). This is the marginal zone (MZ) of the
developing CNS, and it is where the ﬁrst mature cortical neurons
are born at around E11.5 in mouse (Smart and McSherry, 1982).
ProminentMLLT11 expression was also observed in the developing
lateral ganglionic eminence (LGE). By E13.5 the cortical MZ and
LGE have expanded, and in the preplate (PP) has developed under-
neath the MZ. The expansion of TuJ1-positive post-mitotic neurons
coincident with the broadened expression of MLLT11 in theseFig. 1. Embryonic expression ofMLLT11. (A–C) Whole mount in situ hybridization (ISH) at
MLLT11 is detected in the VII–VIII at E9.5. TE and OV staining with anti-sense (left) and se
at E9.5. (B) At E10.5,MLLT11 expression corresponded to Tuj1-positive cranial ganglia and
(arrows, B). (C) E12.5 whole ISH showing MLLT11 expression in the spinal cord and DRG
acoustic complex; IX, glossopharyngeal ganglion; X, vagus ganglion; DRG, dorsal root garegions (Fig. 2B–B00). By E16.5,MLLT11 transcripts were abundantly
expressed in post-migratory neurons that form the cortical plate
(CP) and subplate (SP), whereas it was negative in the ventricular
zone (VZ) where Sox2-positive neural progenitors reside (Fig. 2C-
C00). At this stage, MLLT11 is faintly detectable in the intermediate
zone (IZ) of the developing cortex (Fig. 2C-C0). Since the IZ is a rel-
atively cell-sparse zone containing migrating post-mitotic neurons
reaching the CP and tangentially migrating interneurons (Kwan
et al., 2012), this suggests that MLLT11 is largely speciﬁc for
post-mitotic neurons in the developing cortex.
In order to clarify whether MLLT11 expressed in intermediate
cortical progenitors, we conducted co-labeling experiments in
E11.5 and E13.5 forebrains using anti-MLLT11, Tbr2, and Mash1
antibodies. Tbr2 is expressed in intermediate progenitors contrib-
uting to the cortical plate, while Mash1 expression identiﬁes pro-
genitors in the LGE (Casarosa et al., 1999; Englund et al., 2005).
At the start of corticogenesis, we found that MLLT11 co-localized
with Tbr2 in the MZ at E11.5 (⁄, Fig. 3A and A0). By E13.5, the SP
has developed (which delineates the future cortical plate) and
expressed Tbr2 (Fig 3B). MLLT11 protein co-labeled with Tbr2 in
the SP and MZ, but not in the IZ (Fig. 3B). In contrast, MLLT11
and Mash1 expression were mutually exclusive in the developing
LGE, with MLLT11 localizing to the postmitotic MZ and Mash1
restricted to germinal (VZ/SVZ) region bordering the ventricle of
the LGE (Fig. 3C). At E13.5 we observed continued Mash1 staining
in the germinal VZ/SVZ of the ganglionic eminence, while MLLT11
expression was restricted to the differentiated neurons of the LGE
(Fig. 3D). At E16.5 both Tbr2 and Mash1 were absent from the fetal
forebrain, but MLLT11 continued in the cortical plate (Fig. 2C-C00,
data not shown).
In immunohistochemistry experiments (IHC), we used a veri-
ﬁed commercial monoclonal antibody directed against MLLT11
(see Section 3). The anti-MLLT11 antibody signal closely paralleled
that of the MLLT11 riboprobe, particularly at early stages of
neurogenesis. However at E13.5 and E16.5 MLLT11 immunostain-
ing only weekly detected post-mitotic neurons in the cortex, spinal
cord, and eye, and increasingly gave non-speciﬁc signals in theE9.5, E10.5, and E12.5 and whole mount immunohistochemistry (IHC) for Tuj1. (A)
nse (right) riboprobes (A and B). (A0) Tuj1 was detected in the V and VII–VIII ganglia
DRG (B0). Expression was detected in the basal plate of the hindbrain and midbrain
. Scale bars: 1 mm for A and B. Abbreviations: V, trigeminal ganglia; VII–VIII, facio-
nglia; TE, telencephalon; OV, otic vesicle.
Fig. 2. MLLT11 expression during corticogenesis. (A) MLLT11 transcripts were detected in the MZ, LGE, and in differentiating neurons of the FP (⁄), but not in the VZ, of the
developing forebrain at E11.5. (A0) High magniﬁcation view of MLLT11 expression in the outermost layer of neuroepithelium at E11.5, which was positive for Tuj1, a mature
neuron marker (A00). (B) At E13.5, MLLT11 transcripts localized to the differentiating neuronal layers of the MZ and LGE. (B0) High magniﬁcation view ofMLLT11 expression in
the PP and MZ, but not VZ, of the developing cortex at E13.5. (B00) Immunohistochemistry (IHC) for Tuj1 (green) and Sox2 (red) of an adjacent section of B0 . The MLLT11-
positive layer becomes thicker as mature neurons increase, indicated by Tuj1 IHC (green) (B00). (C–C00) Section ISH (C) and a cut surface of whole mount ISH (C0) at E16.5
showingMLLT11 transcripts in the CP and SP, which are the anlage of the cortex containing post-migratory Tuj1-positive neurons (C00). A low level ofMLLT11 in the IZ, but no
expression was observed in the VZ. (C00) IHC on adjacent sections to (C) for Sox2 (red), Tuj1 (green), and DAPI (blue) for identiﬁcation of speciﬁc cortical layers: CP, SP, IZ, and
VZ. Scale bars: 80 lm for A, B, and 40 lm for A0 , B0 , C. Abbreviations: CP, cortical plate; CTX, cortex; FP, ﬂoorplate; IHC, immunohistochemistry; IZ, intermediate zone; LGE,
lateral ganglionic eminence; MZ, marginal zone; PP, preplate; SP, subplate; VZ, ventricular zone.
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ing with TuJ1, Sox2, and SMA immunostaining on adjacent sections
to evaluate MLLT11 localization (see below).
1.3. MLLT11 expression in the spinal cord
In the spinal cord, MLLT11 transcripts were ﬁrst detected in the
ventral horn and DRG at E10.5 (Fig. 4A), overlapping with Tuj1
(Fig. 4A0). At E11.5 MLLT11 expression expanded to interneurons
in the developing marginal zone of the spinal cord and adjacent
dorsal root ganglion (Fig. 4B-B0). By E13.5 MLLT11 transcripts are
detected throughout the expanded MZ, with high levels in the lat-
eral motor column (LMC) in the ventral horn (Fig. 4C). Again, no
expression was observed in the Sox2-positive VZ at any of thestages examined (Fig. 4A-C vs. 4A00–C00). We next performed IHC
for MLLT11 to examine its expression in the spinal cord
(Fig. 4A0–C0). Both approaches revealed MLLT11 expression in the
DRG, MZ and developing motor pools at E10.5–E11.5. However,
as later stages, only weak MLLT11 protein expression was noted
in the E13.5 spinal cord (Fig. 4C0), in contrast to the stronger ISH
signal in Fig. 3C, particularly in the LMC. Also, non-speciﬁc immu-
nochemical signals were detected in the epithelium, mesenchyme,
and endothelium (Fig. 4B0 and C0), which were negative forMLLT11
mRNA in ISH experiments (Fig. 4B and C). We conclude that
MLLT11 expression is speciﬁc for post-mitotic spinal cord neurons
and may play a role in motor neuron development as evidenced by
its pronounced expression in this population in the embryonic
spinal cord.
Fig. 3. Co-localization of MLLT11 with intermediate cortical progenitor markers. (A–A0) Low and high magniﬁcation views of IHC of MLLT11 (red) and Tbr2 (green) in the
forebrain at E11.5. MLLT11 was detected in Tbr2-positive cells (arrows) in the presumptive SP region of the forebrain. (B) IHC of MLLT11 and Tbr2 in the E13.5 cortex, showing
co-expression in the SP. (C–D) MLLT11 (red) and Mash1 (green) IHC in the ganglionic eminence at E11.5 (C) and E13.5 (D). MLLT11 was detected in differentiating neurons of
the MZ, which contrasted with the localization of Mash1 to the progenitors of the germinal region (VZ/SVZ). Abbreviations as in Fig. 2; SVZ, subventricular zone. Scale bars:
20 lm.
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We next examinedMLLT11 expression in developing neurons in
the retina and enteric system. During mouse eye development, the
ﬁrst mature cells to appear are ganglion cells, followed by ama-
crine cells, at E11.5–12.5 on the inner surface of the neural retina
proximally to the optic nerve (Hinds and Hinds, 1974; Cayouette
et al., 2006). The histogenesis of retinal ganglion and amacrine cells
reaches high levels by E13.5 and continually localizes to the
inner-most layer of the retina. We did not detect MLLT11 mRNA
(data not shown) or protein (Fig. 5A) in the inner layer of the
E11.5 retina, when the ﬁrst TuJ1-positive neurons appear.
However, by E13.5 we observed robust MLLT11 transcripts in the
developing TuJ1-positive inner cell layer at E13.5, but not in the
Sox2-positive outer layer, which contains retinal progenitors
(Fig. 5B, C). We next performed MLLT11 and Tuj1 IHC and con-
ﬁrmed MLLT11 localization in post-mitotic neurons in the inner
layer of the developing retina at E13.5 (⁄, Fig. 5D–D00). Similarly,
at E16.5 we detected extensive co-localization of MLLT11 and
Tuj1 in the differentiating neurons in the inner retinal neuroepi-
thelium and optic nerve (⁄, Fig. 5E–E00). Thus, MLLT11 expression
coincided with retinal neurogenesis and was restricted to inner
retinal layer on optic nerve during development.
The enteric nervous system develops from the colonization of
enteric neural crest cell migrations during embryogenesis
(Laranjeira and Pachnis, 2009). MLLT11 was not found in migratingenteric neural crest cells at E10.5 and E11.5 (data not shown) but
was detected in mature enteric neurons positive for Tuj1
(Fig. 5F–G0). At E13.5, MLLT11-positive enteric neurons were
located outside of developing inner circular muscle layer, identi-
ﬁed by SMA immunostaining (Fig. 5F, F0), and outer longitudinal
muscle layer (Fig. 5G, G0). These neurons become the future
Auerbach’s (myenteric) plexus (Yamada et al., 2010). Later,MLLT11
was expressed in the submucosal plexus as well (data not shown).
1.5. Subcellular MLLT11 expression in the developing neurepithelium
To examine the subcellular localization of MLLT11 protein
during neural development, we performed immunohistochemistry
for MLLT11 and Tuj1 on cortical sections at E11.5 and E13.5 and
examined the sections under high magniﬁcation using structured
illumination (Fig. 6). MLLT11 was highly enriched in the cytoplasm
of the Tuj1-positive MZ cells of the developing dorsal forebrain at
E11.5 (arrows, Fig. 6A–C0). A similar cytoplasmic localization of
MLLT11 was also observed in MZ neurons at E13.5 (Fig. 6D–D00)
and E16.5 (data not shown). MLLT11 IHC gave a similar pattern
of staining as the cytoskeletal marker Tuj1, which outlined the cor-
tex of the neuron. However, at E11.5 low levels of MLLT11 protein
was also observed in the soma of the MZ neurons, which did not
stain for Tuj1 (arrows, Fig. 6A0 and B0). We conclude that MLLT11
is highly localized to the cytoplasm of differentiating neurons,
but may also be expressed at lower levels in the nuclei of neurons.
Fig. 4. MLLT11 expression during spinal cord development. (A–C) ISH for MLLT11 at E10.5, 11.5 and 13.5. (A) MLLT11 transcripts were detected in ventral horn and DRG at
E10.5. (B) At E11.5, MLLT11 expression expanded to the entire MZ of the developing spinal cord, with higher levels in the MN domain. (C) By E13.5 MLLT11 transcripts are
detected throughout the expanded MZ, with high levels in the LMC in the ventral horn. No expression in the VZ was observed. (A0–C0) IHC for MLLT11 in neighboring sections
of A–C. (A0–B0) MLLT11 expression in the DRG, MZ and developing motor pool at E10.5–E11.5. (C0) Weak MLLT11 protein expression was noted in the E13.5 spinal cord, in
contrast to the stronger ISH signal in C. (A00–C00) IHC for Tuj1 (green) and Sox2 (red) identifying the MZ and VZ progenitor region of the developing spinal cord, respectively.
MLLT11 mRNA (A–C) or protein (A0–C0) expressing region overlapped with Tuj1-positive MZ, and not the Sox2-posive VZ (A00–C00). Scale bars: 50 lm for A–C. Abbreviations:
DRG, dorsal root ganglia; LMC, lateral motor column; MN, motor neuron domain; MZ, marginal zone; VZ, ventricular zone.
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Here we describe the expression of MLLT11, which is member
of a novel class of poorly characterized proteins. We show that
its expression correlated with the differentiation of all types of
neurons, in both the central and peripheral nervous system. The
neuronally restricted expression for MLLT11 suggests that it is
involved in the differentiation and/or maintenance of neurons dur-
ing development. No signiﬁcant expression of eitherMLLT11mRNA
or protein was detected in the germinal (ventricular) regions of the
developing cortex and spinal cord, where neural progenitors
reside. Instead, expression initiated and then intensiﬁed in the
post-mitotic neurons of the developing cortex, spinal cord, eye,
and gut.
During the formation of the sensory ganglia of the head, the ﬁrst
population we observed MLLT11 expression was the facio-acoustic
(VII–VIII) ganglia at E9.5. At this stage Tuj1 immunohistochemistry
detected neurons in both the trigeminal (V) and facio-acoustic
populations. In mice, the ﬁrst mature neurons appear in the cranial
motor nuclei at E9 (Finlay and Darlington, 1995). Thus MLLT11
gene activation seemed to trail the maturation of the cranialganglia, at least at the very earliest stages of sensory development.
This could reﬂect a limitation of the sensitivity of our ISH experi-
ments, or indicate that MLLT11 has a more restricted speciﬁcity
for maturing neurons in the facio-acoustic complex. However, by
E10.5 MLLT11 expression closely paralleled that of Tuj1 immuno-
staining in all the sensory populations of the developing head
and dorsal root ganglia.
Consistent with a role in neural development, we found that
MLTT11 expression closely followed the development of post-
mitotic neurons in the retina and enteric nervous system. Speciﬁ-
cally, MLLT11 expression was consistently localized to the inner
layer of the developing eye, reﬂecting the histogenesis of retinal
ganglion cells (Hinds and Hinds, 1974). It can thus be a useful mar-
ker for the development of this cell type.
In the cortex, we found that MLLT11 mRNA and protein expres-
sion in the developing marginal zone and SP. In the latter region, it
extensively localized with the intermediate progenitor marker
Tbr2, suggesting MLLT11 expression is activated in cortical neu-
rons undergoing terminal differentiation. The SP ultimately gener-
ates all the layers of the cortex, and consistent with this, we
observed extensive MLLT11 expression is the entire cortical plate
Fig. 5. MLLT11 expression in the developing eye and gastrointestinal tract (GIT). (A) IHC of MLLT11 (red) and Tuj1 (green) in the E11.5 eye. MLLT11 levels were undetectable
at E11.5, with only a few Tuj1 cells emerging in the inner retinal layer (⁄). (B) ISH forMLLT11. (C) Sox2 (red) and Tuj1 (green) IHC in the developing eye at E13.5 in an adjacent
section to B.MLLT11 was expressed in Tuj1-positive territory (green, C) in the developing eye at E13.5. (D–D00) IHC for MLLT11 (red) and Tuj1 (Green) showed co-localization
in the inner retinal layer (⁄) in the eye at E13.5. (E–E00) IHC for MLLT11 (red) and Tuj1 (Green) in the eye at E16.5 showed co-localization in the inner retinal layer (⁄) and ON
(arrowhead). (F and F0) E13.5 MLLT11 expression (F) in the Tuj1-positive enteric neurons (green, F0) bounded by the outer layer of developing inner circular muscle layer
positive for a-smooth muscle actin (aSMA, red, F0). (G and G0) MLLT11 expression in enteric neurons of stomach at E16.5. (G0) aSMA (red) and Tuj1 (green) staining of E16.5
sections adjacent to MLLT11 ISH in G. Tuj1 identiﬁed enteric neurons located between the inner circular and outer longitudinal muscle layers positive for aSMA. Scale bars:
50 lm for A–C, F–G0 , 20 lm for D–D00 , 100 lm for E–E00 . Abbreviations: Optic nerve; ON, Retinal neuroepithlium; Rne, Lens; Ls, De.
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Fig. 6. Subcellular localization of MLLT11. (A–C0) MLLT11 IHC in the neuroepithelium at E11.5. MLLT11 (green, A–B0) was expressed in Tuj1-positive neurons (arrows, red, A,
A0 , C, C0). (A0–C0) High magniﬁcation views of MLLT11 co-staining in Tuj1-positive post-mitotic neurons at E11.5. (D–D00) High magniﬁcation views of MLLT11 (green) and Tuj1
(red) IHC in the marginal zone of the E13.5 cortex. MLLT11 protein was largely cytoplasmic in Tuj1-positive post-mitotic neurons at E11.5 and E13.5 (arrows). Scale bars:
25 lm for A–C, 20 lm D–D00 . Abbreviations as in Fig. 2.
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MLLT11 expression was largely excluded from the Mash1-positive
germinal regions and instead localized to the burgeoning MZ. The
restricted expression of MLLT11 in Tuj1-positive tissues through
the central and peripheral nervous system demonstrates that it is
a pan-neuronal marker during development.
Interestingly, MLLT11 protein distribution in developing
neurons showed a predominantly cytoplasmic pattern, with lower
levels in the nucleus. This pattern is similar to one previously
reported in HEK293T cells transfected with MLLT11 expression
constructs, which showed a predominately cytoplasm localization
(Lin et al., 2004). However, they also reported that MLLT11 was
constantly exported from nucleus to cytoplasm, suggesting a pos-
sible role in the nucleus. A more recent ﬁnding has identiﬁed
nuclear localization sequences in the MLLT11 protein and has dem-
onstrated their role in the differentiation of thymocytes (Parcelier
et al., 2011). Our ﬁndings suggest that the intriguing possibility
that nucleo-cytoplasmic shuttling of MLLT11 may also be required
for neural development.
In conclusion, we describe the neuronal expression of MLLT11, a
protein that has been previously described as speciﬁc to the hema-
topoietic system. Our ﬁndings now demonstrate that MLLT11 is a
marker for post-mitotic neurons and suggests a role in neuronaldifferentiation or maintenance during development. Future work
will focus on elucidating the mechanisms of MLLT11 function in
developing neurons using loss- and gain-of-function approaches
in the vertebrate embryo.2. Experimental procedures
2.1. Animals
FVB (Jackson Laboratory, Bar Harbor, ME) mice were used for
the study. For the expression analysis during embryonic period,
noon of the day when a vaginal plug was conﬁrmed was deﬁned
as E0.5. This study was approved by the Dalhousie animal ethics
committee, and the animals were handled in accordance with the
institutional regulations and guidelines of the Canadian Council on
Animal Care.2.2. RNA in situ hybridization and immunohistochemistry
The full-length FANTOM3 library cDNA clone for the MLLT11
(Clone ID B230333C11) comprising a 305-bp XhoI-SacII fragment
in pBluescript (GenBank Acc. No. NM_019914.4). To generate
M. Yamada et al. / Gene Expression Patterns 15 (2014) 80–87 87antisense and sense digoxigenin-labeled riboprobes for MLLT11
mRNA, the plasmids were linearized with XhoI or SacII and tran-
scribed with T7 and T3 RNA polymerases, respectively.
Embryos were collected from time-mated dams and ﬁxed with
4% paraformaldehyde (PFA)/0.1 M phosphate buffer (PB) at 4 C
overnight. After pretreatment with proteinase K (10 lg/ml), it
was hybridized overnight with a sense or an anti-sense RNA probe
at 65 C in hybridization buffer (50% formamide, 5 SSC, 1% SDS,
and 0.1 mg/ml yeast tRNA). The embryo was incubated with alka-
line phosphatase-conjugated anti-digoxigenin Fab fragments
(1:2000; Roche, Mannheim, Germany) at 4 C overnight, followed
by incubation with 5-bromo-4-chloro-3-indoyl phosphate (BCIP)/
nitroblue tetrazolium (NBT) for visualization. For section in situ
hybridization, following overnight ﬁxation with 4% PFA/0.1 M PB,
tissues were processed into O.C.T. block (Sakura Finetek, Torrance,
CA), sectioned at 14 mm, post-ﬁxed in 4% PFA/0.1 M PB. The sec-
tions were treated with 1 lg/ml of proteinase K and followed by
post-ﬁxation in 4% PFA/0.25% glutalaldehyde/0.1 M PB. Hybridiza-
tion was performed at 60 C overnight in hybridization buffer (50%
formamide, 5 SSC, 5% dextran sulfate, 1 Denhardt’s solution and
0.5 mg/ml yeast tRNA) (Yokota et al., 2007).
Immunohistochemistry was conducted as described previously
(Iulianella et al., 2008). The following antibodies were used for
immunohistochemistry: anti-MLLT11 (mouse, 2A9-1B7, 1:500,
Abnova, Taipei, Taiwan), anti-Tuj1 (rabbit, 1-15-79, 1:1000, Cov-
ance, Dedham, MA), anti-aSMA (mouse, 1A4, 1:500, Sigma, St.
Louis, MO), anti-Sox2 (goat, 1:250, Santa Cruz Biotechnology, Santa
Cruz, CA), anti-Tbr2 (chicken, 1:1000, Millipore, Temecula, CA), and
anti-Mash1 (goat, 1:250, R and D Systems, Minneapolis, MN). The
images were captured by a Zeiss inverted AxioObserver wide ﬁeld
microscope with Apotome 2 and 10, 20, 40, and 63 oil objec-
tives, using a Zeiss Mrm or Hammatsu Orca Flash digital camera
and process using Zen software (Zeiss, Germany).
Whole mouse TuJ1 immunostaining of E9.5 and E10.5 mouse
embryos was performed as described previously (Sandell et al.,
2011). Images were captured with AxioVision software using a
Zeiss V8 pentaﬂuor epiﬂuorescence stereo microscope equipped
with Axiocam CM1 digital camera and a 0.63 apachromat lens
(Zeiss, Germany). All images were labeled using Adobe Photoshop
CS4 software (Adobe, San Jose, California).
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